PENTASA Side Effects

6987269-4 | Breast Cancer, Product Quality Issue
on Sep 04, 2010 Female patient from UNITED STATES , 68 years of age, weighting 158.0 lb, was diagnosed with crohn's disease (What is crohn's disease?), gastrooesophageal reflux disease and was treated with Pentasa (View Usage). Patient experienced the following unwanted or unexpected effects: breast cancer (What is breast cancer?), product quality issue. Pentasa dosage: 500 Mg X 8 Capsules, 1x/day:qd. During the same period patient was treated with PROTONIX (40 Mg, 1x/day:qd) (View Protonix Review and Protonix Label ).

6882593-8 | Anxiety Disorder, Crohn's Disease, Off Label Use, Product Quality Issue, Product Taste Abnormal, Vomiting
Patient was taking Pentasa (View Usage). Patient had the following side effects: anxiety disorder, crohn's disease (What is crohn's disease?), off label use, product quality issue, product taste abnormal, vomiting on Apr 27, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 145.1 lb, was diagnosed with crohn's disease (What is crohn's disease?) and. Pentasa dosage: 1 G Daily, Oral. During the same period patient was treated with TUMS /00108001/ (CALCIUM CARBONATE) TABLET (View Tums /00108001/ (calcium Carbonate) Tablet Review and Tums /00108001/ (calcium Carbonate) Tablet Label ), FERROUS GLUCONATE (FERROUS GLUCONATE) TABLET (View Ferrous Gluconate (ferrous Gluconate) Tablet Review and Ferrous Gluconate (ferrous Gluconate) Tablet Label ). Patient was hospitalized.

6882592-6 | Abdominal Pain, Chills, Pyrexia, Vomiting
Adverse event was reported on Feb 08, 2010 by a Male patient taking Pentasa (View Usage) (Dosage: 900 Mg, 1x/day:qd, Oral) was diagnosed with colitis ulcerative and. Location: UNITED STATES , 53 years of age, weighting 172.0 lb, After Pentasa was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), chills, pyrexia, vomiting. During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ). Patient was hospitalized.

6882576-8 | Chest Discomfort, Dementia, Hypersensitivity, Neuropathy Peripheral, Off Label Use, Sleep Disorder
on Sep 24, 2009 Male patient from UNITED STATES , 72 years of age, weighting 125.0 lb, was diagnosed with crohn's disease (What is crohn's disease?) and was treated with Pentasa (View Usage). Patient experienced the following unwanted or unexpected effects: chest discomfort, dementia (What is dementia?), hypersensitivity, neuropathy peripheral, off label use, sleep disorder (What is sleep disorder?). Pentasa dosage: 4000 Mg, 1x/day;qd, Oral; 2000 Mg, 1xday:qd, Oral. During the same period patient was treated with CHOLESTYRAMINE (COLESTYRAMINE) (View Cholestyramine (colestyramine) Review and Cholestyramine (colestyramine) Label ), LOPERAMIDE (LOPERAMIDE) (View Loperamide (loperamide) Review and Loperamide (loperamide) Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), CALCIUM (CALCIUM) (View Calcium (calcium) Review and Calcium (calcium) Label ), SEE IMAGE (View See Image Review and See Image Label ), METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ). Patient was hospitalized.


6882572-0 | Off Label Use, Thrombocytopenia
on Feb 12, 2010 Male patient from UNITED STATES , weighting 185.0 lb, was diagnosed with crohn's disease (What is crohn's disease?) and was treated with Pentasa (View Usage). Patient had the following side effects: off label use, thrombocytopenia. Pentasa dosage: 1000 Mg, 4x/day;qid, Oral. During the same period patient was treated with FOLIC ACID (View Folic Acid Review and Folic Acid Label ).

6526504-3 | Swollen Tongue
Patient was taking Pentasa (View Usage). After Pentasa was administered, patient had the following side effects: swollen tongue on Dec 22, 2009 from UNITED STATES Additional patient health information: Female patient , 65 years of age, weighting 130.1 lb, was diagnosed with colitis and. Pentasa dosage: 1000 Mg, 4x/day:qid, Oral. During the same period patient was treated with ANTIHYPERTENSIVES (View Antihypertensives Review and Antihypertensives Label ).

6521160-2 | Alopecia, Intestinal Obstruction, Off Label Use, Thrombosis
Adverse event was reported on Dec 16, 2009 by a Female patient taking Pentasa (View Usage) (Dosage: 500 Mg,2x/day:bid, Oral) was diagnosed with crohn's disease (What is crohn's disease?) and. Location: UNITED STATES , 76 years of age, Patient experienced the following unwanted or unexpected effects: alopecia, intestinal obstruction, off label use, thrombosis. During the same period patient was treated with BUDESONIDE (View Budesonide Review and Budesonide Label ), LIBRAX (View Librax Review and Librax Label ), RYTHMOL /00546302/ (PROPAFENONE HYDROCHLORIDE) (View Rythmol /00546302/ (propafenone Hydrochloride) Review and Rythmol /00546302/ (propafenone Hydrochloride) Label ), LANOXIN (View Lanoxin Review and Lanoxin Label ), WELCHOL (View Welchol Review and Welchol Label ), FLORESTOR /01686601/ (SACCHAROMYCES BOULARDIL LYOPHILIZED) (View Florestor /01686601/ (saccharomyces Boulardil Lyophilized) Review and Florestor /01686601/ (saccharomyces Boulardil Lyophilized) Label ).

6512810-5 | Swollen Tongue
on Dec 08, 2009 Female patient from UNITED STATES , 65 years of age, was treated with Pentasa (View Usage). Patient had the following side effects: swollen tongue. Pentasa dosage: 500 Mg, 4x/day;qid, Oral. During the same period patient was treated with ANTIHYPERTENSIVES (View Antihypertensives Review and Antihypertensives Label ).

6346666-0 | Acute Febrile Neutrophilic Dermatosis, Arthralgia, Back Pain, Cardiac Failure, Haemodynamic Instability, Hepatic Failure, Hyperthermia, Inflammation, Multi-organ Failure
on Aug 27, 2009 Male patient from FRANCE , 40 years of age, was diagnosed with colitis ulcerative and was treated with Pentasa (View Usage). After Pentasa was administered, patient had the following side effects: acute febrile neutrophilic dermatosis, arthralgia, back pain (What is back pain?), cardiac failure, haemodynamic instability, hepatic failure, hyperthermia, inflammation, multi-organ failure. Pentasa dosage: . During the same period patient was treated with AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ), CORTICOSTEROIDS (2 Mg/kg/day;) (View Corticosteroids Review and Corticosteroids Label ).

6326239-6 | Anxiety, Chronic Lymphocytic Leukaemia, Crohn's Disease, Diabetes Mellitus, Lip And/or Oral Cavity Cancer Recurrent, Off Label Use, Small Intestinal Obstruction
Patient was taking Pentasa (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), chronic lymphocytic leukaemia, crohn's disease (What is crohn's disease?), diabetes mellitus, lip and/or oral cavity cancer recurrent, off label use, small intestinal obstruction on Aug 14, 2009 from UNITED STATES Additional patient health information: Female patient , 75 years of age, was diagnosed with irritable bowel syndrome (What is irritable bowel syndrome?) and. Pentasa dosage: 4000 Mg, 1x/day: Qd, Oral, 2000 Mg, 1x/day:qd, Oral. During the same period patient was treated with LOMOTIL (View Lomotil Review and Lomotil Label ), REMICADE (View Remicade Review and Remicade Label ), COZAAR (View Cozaar Review and Cozaar Label ), COLESTIPOL HYDROCHLORIDE (View Colestipol Hydrochloride Review and Colestipol Hydrochloride Label ), POTASSIUM (POTASSIUM) (View Potassium (potassium) Review and Potassium (potassium) Label ). Patient was hospitalized.

6312483-0 | Anxiety, Chronic Lymphocytic Leukaemia, Crohn's Disease, Diabetes Mellitus, Diarrhoea, Lip And/or Oral Cavity Cancer, Neoplasm Recurrence, Off Label Use, Small Intestinal Obstruction
Adverse event was reported on Jul 29, 2009 by a Female patient taking Pentasa (View Usage) (Dosage: 4000 Mg, 1x/day;qd, Oral; 4000 Mg, 1x/day;qd, Oral; 2000 Mg, 1x/day:qd, Oral) was diagnosed with irritable bowel syndrome (What is irritable bowel syndrome?) and. Location: UNITED STATES , 75 years of age, Patient had the following side effects: anxiety (What is anxiety?), chronic lymphocytic leukaemia, crohn's disease (What is crohn's disease?), diabetes mellitus, diarrhoea, lip and/or oral cavity cancer, neoplasm recurrence, off label use, small intestinal obstruction. During the same period patient was treated with LOMOTIL /00034001/ (ATROPINE SULFATE, DIPHENOXYLATE HYDROCHLORIDE) (View Lomotil /00034001/ (atropine Sulfate, Diphenoxylate Hydrochloride) Review and Lomotil /00034001/ (atropine Sulfate, Diphenoxylate Hydrochloride) Label ), REMICADE (View Remicade Review and Remicade Label ), COZAAR (View Cozaar Review and Cozaar Label ), COLESTIPOL HYDROCHLORIDE (COLESTIPOL HYDROCHORIDE) (View Colestipol Hydrochloride (colestipol Hydrochoride) Review and Colestipol Hydrochloride (colestipol Hydrochoride) Label ), POTASSIUM (POTASSIUM) (View Potassium (potassium) Review and Potassium (potassium) Label ). Patient was hospitalized.

6289071-8 | Crohn's Disease, Hypovolaemia, Malnutrition, Sinusitis, Unevaluable Event, Urinary Tract Infection, Vomiting
on Jul 21, 2009 Male patient from UNITED STATES , 81 years of age, weighting 175.0 lb, was diagnosed with colitis ulcerative, crohn's disease (What is crohn's disease?) and was treated with Pentasa (View Usage). After Pentasa was administered, patient had the following side effects: crohn's disease (What is crohn's disease?), hypovolaemia, malnutrition, sinusitis (What is sinusitis?), unevaluable event, urinary tract infection (What is urinary tract infection?), vomiting. Pentasa dosage: 1000 Mg, 4x/day:qid, Oral. Patient was hospitalized.

6235679-5 | Abasia, Off Label Use, Weight Decreased
on Jun 11, 2009 Male patient from UNITED STATES , 35 years of age, weighting 175.0 lb, was diagnosed with crohn's disease (What is crohn's disease?) and was treated with Pentasa (View Usage). Patient experienced the following unwanted or unexpected effects: abasia, off label use, weight decreased. Pentasa dosage: 500 Mg, 1x/day; Qd Oral. During the same period patient was treated with ELAVIL (View Elavil Review and Elavil Label ), TRANXENE (View Tranxene Review and Tranxene Label ). Patient was hospitalized.

6232929-6 | Feeding Tube Complication, Nausea, Off Label Use
Patient was taking Pentasa (View Usage). Patient had the following side effects: feeding tube complication, nausea (What is nausea?), off label use on May 29, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 97.89 lb, was diagnosed with crohn's disease (What is crohn's disease?) and. Pentasa dosage: 1750 Mg Daily Via G-tube. During the same period patient was treated with CARAFATE (View Carafate Review and Carafate Label ), COLACE (DOCUSATE SODIUM) (View Colace (docusate Sodium) Review and Colace (docusate Sodium) Label ), CALCIUM (CALCIUM) (View Calcium (calcium) Review and Calcium (calcium) Label ), DALLERGY (CHLORPHENAMINE MALEATE, HYOSCINE METHONITRATE, PHENYLEPHRIE (View Dallergy (chlorphenamine Maleate, Hyoscine Methonitrate, Phenylephrie Review and Dallergy (chlorphenamine Maleate, Hyoscine Methonitrate, Phenylephrie Label ), MIRALAX (View Miralax Review and Miralax Label ), SINGULAIR /01362602/ (MONTELUKAST SODIUM) (View Singulair /01362602/ (montelukast Sodium) Review and Singulair /01362602/ (montelukast Sodium) Label ), PEPCID /00706001/ (FAMOTIDINE) (View Pepcid /00706001/ (famotidine) Review and Pepcid /00706001/ (famotidine) Label ), BENTYL (View Bentyl Review and Bentyl Label ).

6215429-9 | Condition Aggravated, Crohn's Disease, Depression, Incorrect Dose Administered, Infection, Intestinal Fistula, Nausea, Off Label Use
Adverse event was reported on May 29, 2009 by a Female patient taking Pentasa (View Usage) (Dosage: 4 G Daily, Oral ; 1.5 G Daily, Oral) was diagnosed with crohn's disease (What is crohn's disease?) and. Location: UNITED STATES , weighting 127.0 lb, After Pentasa was administered, patient had the following side effects: condition aggravated, crohn's disease (What is crohn's disease?), depression (What is depression?), incorrect dose administered, infection (What is infection?), intestinal fistula, nausea (What is nausea?), off label use. During the same period patient was treated with NAPRONAC (NAPROXEN) (View Napronac (naproxen) Review and Napronac (naproxen) Label ). Patient was hospitalized.

6212595-6 | Back Pain, Fatigue, Headache, Myocarditis, Neck Pain, Pyrexia
on Jun 02, 2009 Female patient from UNITED STATES , weighting 148.0 lb, was diagnosed with gastrointestinal erosion, large intestinal ulcer and was treated with Pentasa (View Usage). Patient experienced the following unwanted or unexpected effects: back pain (What is back pain?), fatigue, headache (What is headache?), myocarditis, neck pain, pyrexia. Pentasa dosage: 1,000 Mg Three Times A Day 047. During the same period patient was treated with HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), COLACE (View Colace Review and Colace Label ). Patient was hospitalized.

6211959-4 | Abdominal Pain Upper, Condition Aggravated, Crohn's Disease, Depression, Gastrointestinal Infection, Intestinal Fistula, Nausea, Off Label Use, Underdose
on May 18, 2009 Female patient from UNITED STATES , 31 years of age, weighting 125.0 lb, was diagnosed with crohn's disease (What is crohn's disease?) and was treated with Pentasa (View Usage). Patient had the following side effects: abdominal pain upper, condition aggravated, crohn's disease (What is crohn's disease?), depression (What is depression?), gastrointestinal infection, intestinal fistula, nausea (What is nausea?), off label use, underdose. Pentasa dosage: 4 G, 1x/2wks, Oral; 1.5 G, 1x/day:qd, Oral. During the same period patient was treated with NAPRONAC (NAPROXEN) (View Napronac (naproxen) Review and Napronac (naproxen) Label ). Patient was hospitalized.

6186715-6 | Abdominal Pain, Accidental Exposure, Appendix Disorder, Gallbladder Non-functioning, Off Label Use, Ovarian Cyst
Patient was taking Pentasa (View Usage). After Pentasa was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), accidental exposure, appendix disorder, gallbladder non-functioning, off label use, ovarian cyst (What is ovarian cyst?) on Apr 30, 2009 from UNITED STATES Additional patient health information: Female patient , 33 years of age, weighting 185.0 lb, was diagnosed with crohn's disease (What is crohn's disease?), irritable bowel syndrome (What is irritable bowel syndrome?) and. Pentasa dosage: 500 Mg, 4x/day:qid, Oral; 500 Mg, 2x/day:bid, Oral. During the same period patient was treated with NEXIUM (View Nexium Review and Nexium Label ). Patient was hospitalized.

6186708-9 | Abdominal Abscess, Abscess Rupture, Dysuria, Pyrexia
Adverse event was reported on Apr 29, 2009 by a Male patient taking Pentasa (View Usage) (Dosage: 250 Mg, 4x/day Qid, Oral; 1000 Mg, 1x/day Qd, Oral; 2000 Mg, 1x/day Qd, Oral) was diagnosed with crohn's disease (What is crohn's disease?) and. Location: UNITED STATES , 25 years of age, weighting 112.0 lb, Patient experienced the following unwanted or unexpected effects: abdominal abscess, abscess rupture, dysuria, pyrexia. Patient was hospitalized.

6186706-5 | Alopecia, Blood Potassium Decreased, Cholelithiasis, Constipation, Crohn's Disease, Gastrooesophageal Reflux Disease, Hypothyroidism, Parkinson's Disease, Resorption Bone Increased
on Apr 28, 2009 Female patient from UNITED STATES , 86 years of age, weighting 104.9 lb, was diagnosed with intestinal functional disorder and was treated with Pentasa (View Usage). Patient had the following side effects: alopecia, blood potassium decreased, cholelithiasis, constipation (What is constipation?), crohn's disease (What is crohn's disease?), gastrooesophageal reflux disease, hypothyroidism, parkinson's disease (What is parkinson's disease?), resorption bone increased. Pentasa dosage: 1000mg, 2x/day:bid, Oral; 1000mg, 2x/day:bid, Oral. During the same period patient was treated with FEXOFENADINE HCL (View Fexofenadine Hcl Review and Fexofenadine Hcl Label ), LAMICTAL (View Lamictal Review and Lamictal Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ).

6169291-3 | Condition Aggravated, Constipation, Crohn's Disease, Off Label Use, Pyrexia, Swelling Face, Swollen Tongue, Vision Blurred
on Apr 20, 2009 Female patient from UNITED STATES , 38 years of age, weighting 187.0 lb, was diagnosed with crohn's disease (What is crohn's disease?) and was treated with Pentasa (View Usage). After Pentasa was administered, patient had the following side effects: condition aggravated, constipation (What is constipation?), crohn's disease (What is crohn's disease?), off label use, pyrexia, swelling face, swollen tongue, vision blurred. Pentasa dosage: Oral, 8 Df, 1x/day, Qd, Oral. During the same period patient was treated with BUDESONIDE (3 Mg, 3x/day, Tid, Oral) (View Budesonide Review and Budesonide Label ). Patient was hospitalized.

6050047-7 | Beta Haemolytic Streptococcal Infection, Off Label Use, Pulmonary Embolism, Pyoderma Gangrenosum, Renal Failure, Vasculitis
Patient was taking Pentasa (View Usage). Patient experienced the following unwanted or unexpected effects: beta haemolytic streptococcal infection, off label use, pulmonary embolism (What is pulmonary embolism?), pyoderma gangrenosum, renal failure, vasculitis (What is vasculitis?) on Jan 07, 2009 from UNITED STATES Additional patient health information: Female patient , 65 years of age, weighting 145.1 lb, was diagnosed with crohn's disease (What is crohn's disease?), diabetes mellitus and. Pentasa dosage: 1000 Mg, Daily, Oral. During the same period patient was treated with GLUCOPHAGE (Mg, Daily, Oral) (View Glucophage Review and Glucophage Label ), ALLERGA /01314202/ (FEXOFENADINE HYDROCHLORIDE) (View Allerga /01314202/ (fexofenadine Hydrochloride) Review and Allerga /01314202/ (fexofenadine Hydrochloride) Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), LEVOXYL (View Levoxyl Review and Levoxyl Label ), NEXIUM (View Nexium Review and Nexium Label ), PERCOCET /0086790/ (OXYCODONE HYDROCHLORIDE, PARACETAMOL) TABLET (View Percocet /0086790/ (oxycodone Hydrochloride, Paracetamol) Tablet Review and Percocet /0086790/ (oxycodone Hydrochloride, Paracetamol) Tablet Label ), STARLIX (View Starlix Review and Starlix Label ), ATENOLOL (View Atenolol Review and Atenolol Label ). Patient was hospitalized.

5955991-4 | Encephalitis Viral, Off Label Use
Adverse event was reported on Oct 28, 2008 by a Male patient taking Pentasa (View Usage) (Dosage: Df, Oral) was diagnosed with autism (What is autism?), ileitis and. Location: UNITED STATES , child 11 years of age, weighting 67.90 lb, Patient had the following side effects: encephalitis viral, off label use. During the same period patient was treated with ZOLOFT /01011402/ (SERTRALINE HYDROCHLORIDE) (View Zoloft /01011402/ (sertraline Hydrochloride) Review and Zoloft /01011402/ (sertraline Hydrochloride) Label ), DIFLUCAN (View Diflucan Review and Diflucan Label ), PROBIOTICS (BACTERIA NOS) (View Probiotics (bacteria Nos) Review and Probiotics (bacteria Nos) Label ), VITAMIN C /00008001/ (ASCORBIC ACID) (View Vitamin C /00008001/ (ascorbic Acid) Review and Vitamin C /00008001/ (ascorbic Acid) Label ). Patient was hospitalized.

5935192-6 | Colitis Ulcerative, Condition Aggravated, Exercise Electrocardiogram Abnormal, Hypotension, Left Ventricular Hypertrophy, Nodal Rhythm, Sinus Arrest, Sinus Bradycardia, Ventricular Dysfunction
on Oct 16, 2008 Female patient from UNITED STATES , 29 years of age, was diagnosed with colitis ulcerative and was treated with Pentasa (View Usage). After Pentasa was administered, patient had the following side effects: colitis ulcerative, condition aggravated, exercise electrocardiogram abnormal, hypotension, left ventricular hypertrophy, nodal rhythm, sinus arrest, sinus bradycardia, ventricular dysfunction. Pentasa dosage: 1 G, 4xday:qid, Oral. During the same period patient was treated with LOPERAMIDE HCL (View Loperamide Hcl Review and Loperamide Hcl Label ). Patient was hospitalized.

5924752-4 | Colitis Ulcerative, Gallbladder Operation
on Oct 03, 2008 Female patient from UNITED STATES , 45 years of age, weighting 123.0 lb, was diagnosed with colitis ulcerative and was treated with Pentasa (View Usage). Patient experienced the following unwanted or unexpected effects: colitis ulcerative, gallbladder operation. Pentasa dosage: 2000 Mg, 1x/day:qd, Oral; 4000 Mg, 1x/day:qd, Oral. Patient was hospitalized.

5918342-7 | Colitis Ulcerative, Condition Aggravated, Gallbladder Operation
Patient was taking Pentasa (View Usage). Patient had the following side effects: colitis ulcerative, condition aggravated, gallbladder operation on Oct 03, 2008 from UNITED STATES Additional patient health information: Female patient , 45 years of age, weighting 123.0 lb, was diagnosed with colitis ulcerative and. Pentasa dosage: 2000 Mg,4000 Mg, 1x/day;qd, Oral. Patient was hospitalized.

5908348-6 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Bilirubin Increased, Blood Lactate Dehydrogenase Increased, Fatigue, Haemoglobin Decreased, Nausea, Off Label Use
Adverse event was reported on Sep 15, 2008 by a Female patient taking Pentasa (View Usage) (Dosage: 4 X 500 Mg Tablets, 2x/day; Bid; Oral) was diagnosed with crohn's disease (What is crohn's disease?) and. Location: UNITED STATES , 29 years of age, weighting 160.9 lb, After Pentasa was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, blood lactate dehydrogenase increased, fatigue, haemoglobin decreased, nausea (What is nausea?), off label use. During the same period patient was treated with MERCAPTOPURINE (100 Mg, 1x/day;qd; Oral, 150 Mg, 1x/dayqd, Oral,) (View Mercaptopurine Review and Mercaptopurine Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), CHLORDIAZEPOXIDE (View Chlordiazepoxide Review and Chlordiazepoxide Label ). Patient was hospitalized.

5835486-9 | Encephalitis Viral
on Jul 24, 2008 Male patient from UNITED STATES , child 11 years of age, weighting 67.90 lb, was treated with Pentasa (View Usage). Patient experienced the following unwanted or unexpected effects: encephalitis viral. Pentasa dosage: Oral. Patient was hospitalized.

5810447-4 | Pericarditis
on Jan 15, 2008 Male patient from UNITED STATES , 32 years of age, was diagnosed with colitis ulcerative and was treated with Pentasa (View Usage). Patient had the following side effects: pericarditis. Pentasa dosage: 800 Mg, 3x/day:tid. During the same period patient was treated with INDOMETHACIN /00003801/ (INDOMETACIN) (View Indomethacin /00003801/ (indometacin) Review and Indomethacin /00003801/ (indometacin) Label ). Patient was hospitalized.

5810013-0 | Hypersensitivity, Vomiting
Patient was taking Pentasa (View Usage). After Pentasa was administered, patient had the following side effects: hypersensitivity, vomiting on Jun 04, 2007 from UNITED STATES Additional patient health information: Male patient , child 11 years of age, weighting 125.9 lb, was diagnosed with crohn's disease (What is crohn's disease?) and. Pentasa dosage: . During the same period patient was treated with MILK OF MAGNESIA TAB (View Milk Of Magnesia Tab Review and Milk Of Magnesia Tab Label ), MAALOX /00082501/ (ALUMINUM HYDROXIDE, MAGNESIUM HYDROXIDE) (View Maalox /00082501/ (aluminum Hydroxide, Magnesium Hydroxide) Review and Maalox /00082501/ (aluminum Hydroxide, Magnesium Hydroxide) Label ), NASONEX (MOMETASONE FUROATE) NASAL SPRAY (View Nasonex (mometasone Furoate) Nasal Spray Review and Nasonex (mometasone Furoate) Nasal Spray Label ), STRATTERA (View Strattera Review and Strattera Label ), TENEX (View Tenex Review and Tenex Label ), MIRALAX (View Miralax Review and Miralax Label ). Patient was hospitalized.

5809994-0 | Haematocrit Decreased, Haemoglobin Decreased, White Blood Cell Count Decreased
Adverse event was reported on May 10, 2007 by a Male patient taking Pentasa (View Usage) (Dosage: 1000 Mg 3x's Daily, Oral) was diagnosed with crohn's disease (What is crohn's disease?) and. Location: UNITED STATES , 48 years of age, Patient experienced the following unwanted or unexpected effects: haematocrit decreased, haemoglobin decreased, white blood cell count decreased. During the same period patient was treated with 6 MP(MERCAPOPURINE) (100 Mg Daily) (View 6-mp(mercapopurine) Review and 6-mp(mercapopurine) Label ), QUESTRAN (View Questran Review and Questran Label ).

5809913-7 | Aplastic Anaemia
on Oct 30, 2007 Female patient from UNITED STATES , 52 years of age, was diagnosed with crohn's disease (What is crohn's disease?) and was treated with Pentasa (View Usage). Patient had the following side effects: aplastic anaemia. Pentasa dosage: 1000 Mg Daily.

5788442-3 | Intestinal Obstruction, Sneezing
on Jun 09, 2008 Female patient from UNITED STATES , 79 years of age, weighting 115.1 lb, was diagnosed with crohn's disease (What is crohn's disease?) and was treated with Pentasa (View Usage). After Pentasa was administered, patient had the following side effects: intestinal obstruction, sneezing. Pentasa dosage: 250 Mg, 3x/day; Tid; Oral; 500 Mg, 3x/ Day:tid, Oral. During the same period patient was treated with SPIRIVA (View Spiriva Review and Spiriva Label ), VENTOLIN (View Ventolin Review and Ventolin Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), FLOVENT (View Flovent Review and Flovent Label ), IPRATROPIUM MERCK (IPRATROPIUM BROMIDE) (View Ipratropium Merck (ipratropium Bromide) Review and Ipratropium Merck (ipratropium Bromide) Label ), ALBUTEROL SULFATE /00139501/ (SALBUTAMOL) (View Albuterol Sulfate /00139501/ (salbutamol) Review and Albuterol Sulfate /00139501/ (salbutamol) Label ). Patient was hospitalized.

5727887-4 | Gastrooesophageal Reflux Disease, Hepatomegaly, Hiatus Hernia
Patient was taking Pentasa (View Usage). Patient experienced the following unwanted or unexpected effects: gastrooesophageal reflux disease, hepatomegaly, hiatus hernia on Apr 15, 2008 from UNITED STATES Additional patient health information: Female patient , weighting 190.0 lb, was diagnosed with crohn's disease (What is crohn's disease?) and. Pentasa dosage: 4000 Mg Daily, Oral. During the same period patient was treated with CYMBALTA (View Cymbalta Review and Cymbalta Label ). Patient was hospitalized.

5710573-4 | Acute Respiratory Distress Syndrome, Gastric Ulcer, Post Procedural Haemorrhage
Adverse event was reported on Mar 31, 2008 by a Male patient taking Pentasa (View Usage) (Dosage: 4x/day;qid;oral; 1000 Mg, 4x/day:qid; Oral) was diagnosed with colitis ulcerative and. Location: UNITED STATES , 83 years of age, weighting 134.9 lb, Patient had the following side effects: acute respiratory distress syndrome, gastric ulcer, post procedural haemorrhage. During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ), PLAVIX (View Plavix Review and Plavix Label ). Patient was hospitalized.

5640152-9 | Abdominal Pain Upper
on Feb 26, 2008 Female patient from UNITED STATES , child 10 years of age, weighting 80.00 lb, was diagnosed with crohn's disease (What is crohn's disease?) and was treated with Pentasa (View Usage). After Pentasa was administered, patient had the following side effects: abdominal pain upper. Pentasa dosage: 2 Capsules 3 Times A Day Po.

5616125-9 | Completed Suicide
on Jan 17, 2008 Female patient from UNITED STATES , 17 years of age, weighting 166.0 lb, was diagnosed with crohn's disease (What is crohn's disease?) and was treated with Pentasa (View Usage). Patient experienced the following unwanted or unexpected effects: completed suicide. Pentasa dosage: 14 Unk, One Dose, Oral.

5588088-6 | Blood Creatine Phosphokinase Increased, Muscle Disorder, Muscular Weakness
Patient was taking Pentasa (View Usage). Patient had the following side effects: blood creatine phosphokinase increased, muscle disorder (What is muscle disorder?), muscular weakness on Dec 26, 2007 from JAPAN Additional patient health information: Female patient , 41 years of age, was diagnosed with colitis ulcerative and. Pentasa dosage: 1500 Mg, 1x/day:qd; Oral. During the same period patient was treated with BETAMETHASONE SODIUM PHOSPHATE (View Betamethasone Sodium Phosphate Review and Betamethasone Sodium Phosphate Label ).

5580996-5 | Blood Creatine Phosphokinase Increased, Muscular Weakness
Adverse event was reported on Dec 13, 2007 by a Female patient taking Pentasa (View Usage) (Dosage: 1500 Mg, 1x/day; Qd; Oral) was diagnosed with colitis ulcerative and. Location: JAPAN , 41 years of age, After Pentasa was administered, patient had the following side effects: blood creatine phosphokinase increased, muscular weakness. During the same period patient was treated with BETAMETHASONE SODIUM PHOSPHATE (View Betamethasone Sodium Phosphate Review and Betamethasone Sodium Phosphate Label ).

5575787-5 | Dyskinesia, Dysphonia, Muscle Spasms, Muscular Weakness, Myopia, Tremor
on Dec 18, 2007 Male patient from GERMANY , 65 years of age, was diagnosed with colitis ulcerative and was treated with Pentasa (View Usage). Patient experienced the following unwanted or unexpected effects: dyskinesia, dysphonia, muscle spasms, muscular weakness, myopia, tremor. Pentasa dosage: 1000 Mg, 3x/day;tid, Oral. During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ), GODAMED (ACETYLSALICYLIC ACID) (View Godamed (acetylsalicylic Acid) Review and Godamed (acetylsalicylic Acid) Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ). Patient was hospitalized.

5574115-9 | Pericardial Effusion
on Dec 10, 2007 Female patient from JAPAN , 19 years of age, was diagnosed with colitis ulcerative and was treated with Pentasa (View Usage). Patient had the following side effects: pericardial effusion. Pentasa dosage: 1000 Mg, 3x/day; Tid, Oral; 2250 Mg Daily, Oral. During the same period patient was treated with RABEPRAZOLE SODIUM (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ). Patient was hospitalized.

5574114-7 | Pneumocystis Jiroveci Pneumonia
Patient was taking Pentasa (View Usage). After Pentasa was administered, patient had the following side effects: pneumocystis jiroveci pneumonia on Dec 10, 2007 from JAPAN Additional patient health information: Male patient , 55 years of age, . Pentasa dosage: Oral. During the same period patient was treated with AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ), PREDNISONE (View Prednisone Review and Prednisone Label ). Patient was hospitalized.

5573702-1 | Completed Suicide, Intentional Overdose
Adverse event was reported on Dec 18, 2007 by a Female patient taking Pentasa (View Usage) (Dosage: 14, One Dose, Oral) was diagnosed with crohn's disease (What is crohn's disease?) and. Location: UNITED STATES , 17 years of age, Patient experienced the following unwanted or unexpected effects: completed suicide, intentional overdose.

5572387-8 | Interstitial Lung Disease
on Dec 13, 2007 Female patient from JAPAN , 75 years of age, was diagnosed with colitis ulcerative and was treated with Pentasa (View Usage). Patient had the following side effects: interstitial lung disease. Pentasa dosage: 750 Mg,3x/day;tid, Oral. During the same period patient was treated with LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), METILDIGOXIN (METILDIGOXIN) (View Metildigoxin (metildigoxin) Review and Metildigoxin (metildigoxin) Label ), NIFEDIPINE (View Nifedipine Review and Nifedipine Label ).

5568121-8 | Abdominal Pain, Anaemia, Arthralgia, Atelectasis, Chest Pain, Condition Aggravated, Crohn's Disease, Diarrhoea, Dyspnoea
on Dec 11, 2007 Female patient from UNITED STATES , 31 years of age, was diagnosed with colitis, crohn's disease (What is crohn's disease?) and was treated with Pentasa (View Usage). After Pentasa was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), anaemia, arthralgia, atelectasis, chest pain (What is chest pain?), condition aggravated, crohn's disease (What is crohn's disease?), diarrhoea, dyspnoea. Pentasa dosage: 4 G, 1x/day:qd, Oral. During the same period patient was treated with COLESTID (COLESTID HYDROCHLORIDE) (View Colestid (colestid Hydrochloride) Review and Colestid (colestid Hydrochloride) Label ), ASACOL (View Asacol Review and Asacol Label ). Patient was hospitalized.

5553696-5 | Dehydration, Diarrhoea Haemorrhagic, Dysphagia, Eating Disorder, Emotional Disorder, Eye Pain, Haemoglobin Decreased, Lethargy
Patient was taking Pentasa (View Usage). Patient experienced the following unwanted or unexpected effects: dehydration, diarrhoea haemorrhagic, dysphagia, eating disorder (What is eating disorder?), emotional disorder, eye pain, haemoglobin decreased, lethargy on Nov 29, 2007 from UNITED STATES Additional patient health information: Male patient , 14 years of age, weighting 91.49 lb, was diagnosed with crohn's disease (What is crohn's disease?) and. Pentasa dosage: 2000 Mg, 2x/day:bid, Oral. During the same period patient was treated with ASACOL (1200 Mg, 3x/day:tid, Oral) (View Asacol Review and Asacol Label ), CANASA (1000 Mg, 1x/day: Qd Hs, Rectal) (View Canasa Review and Canasa Label ). Patient was hospitalized.

5553687-4 | Completed Suicide, Intentional Overdose
Adverse event was reported on Dec 05, 2007 by a Female patient taking Pentasa (View Usage) (Dosage: 14, One Dose, Oral) was diagnosed with crohn's disease (What is crohn's disease?) and. Location: UNITED STATES , 17 years of age, Patient had the following side effects: completed suicide, intentional overdose.

5541965-4 | Dehydration
on Nov 21, 2007 Male patient from FRANCE , 28 years of age, was diagnosed with colitis ulcerative and was treated with Pentasa (View Usage). After Pentasa was administered, patient had the following side effects: dehydration. Pentasa dosage: 4 G Daily, Oral; 1 G Daily, Rectal. Patient was hospitalized.

5541964-2 | Interstitial Lung Disease
on Nov 20, 2007 Male patient from JAPAN , 55 years of age, was treated with Pentasa (View Usage). Patient experienced the following unwanted or unexpected effects: interstitial lung disease. Pentasa dosage: Oral. During the same period patient was treated with AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ), PREDNISONE (View Prednisone Review and Prednisone Label ). Patient was hospitalized.

5533909-6 | Interstitial Lung Disease
Patient was taking Pentasa (View Usage). Patient had the following side effects: interstitial lung disease on Nov 13, 2007 from DENMARK Additional patient health information: Female patient , 75 years of age, was diagnosed with colitis ulcerative and. Pentasa dosage: 750 Mg, 3x/day:tid, Oral. During the same period patient was treated with LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), METILDIGOXIN (METILDIGOXIN) (View Metildigoxin (metildigoxin) Review and Metildigoxin (metildigoxin) Label ), NIFEDIPINE (View Nifedipine Review and Nifedipine Label ), PILSICAINIDE HYDROCHLORIDE (PILSICAINIDE HYDROCHLORIDE) (View Pilsicainide Hydrochloride (pilsicainide Hydrochloride) Review and Pilsicainide Hydrochloride (pilsicainide Hydrochloride) Label ), PREDNISOLONE (PRENISOLONE) (View Prednisolone (prenisolone) Review and Prednisolone (prenisolone) Label ), PREDNISOLONE SODIUM PHOSPHATE (PRENISOLONE SODIUM PHOSPHATE) (View Prednisolone Sodium Phosphate (prenisolone Sodium Phosphate) Review and Prednisolone Sodium Phosphate (prenisolone Sodium Phosphate) Label ).